Meta-Analysis Evaluating the Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors in Patients With Acute or Recently Decompensated Heart Failure

Am J Cardiol. 2022 Jun 1:172:171-172. doi: 10.1016/j.amjcard.2022.03.010. Epub 2022 Apr 5.

Authors

Dimitrios Patoulias¹, Michael Doumas¹, George Kassimis², Nikolaos Fragakis³, Christodoulos Papadopoulos³

Affiliations

¹ Second Propaedeutic Department of Internal Medicine.
² Second Department of Cardiology.
³ Third Department of Cardiology, Aristotle University of Thessaloniki, General Hospital "Hippokration," Thessaloniki, Greece.

PMID: 35396145
DOI: 10.1016/j.amjcard.2022.03.010

No abstract available

Publication types

Letter
Meta-Analysis
Comment

MeSH terms

Diabetes Mellitus, Type 2*
Glucose
Heart Failure* / drug therapy
Humans
Sodium
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use
Symporters*

Substances

Sodium-Glucose Transporter 2 Inhibitors
Symporters
Sodium
Glucose